Status:
COMPLETED
Outcomes Following Pulmonary Valve Replacement in Adults
Lead Sponsor:
Emory University
Conditions:
Heart Disease, Congenital
Pulmonary Valve Replacement
Eligibility:
All Genders
18+ years
Brief Summary
One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation. Multiple studies have demonstrated that placement of a ...
Eligibility Criteria
Inclusion
- Adult patients who have received a pulmonary valve replacement for congenital heart disease at Children's Healthcare of Atlanta at Egleston or are in the Emory Healthcare System between 1976 and 2004.
- \-
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
End Date :
November 1 2005
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00276237
Start Date
July 1 2005
End Date
November 1 2005
Last Update
November 26 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
2
Emory Healthcare System
Atlanta, Georgia, United States, 30322